Daratumumab plus bortezomib, melphalan, and prednisone in East Asian patients with non-transplant multiple myeloma: subanalysis of the randomized phase 3 ALCYONE trial
Titel:
Daratumumab plus bortezomib, melphalan, and prednisone in East Asian patients with non-transplant multiple myeloma: subanalysis of the randomized phase 3 ALCYONE trial
Auteur:
Fujisaki, Tomoaki Ishikawa, Takayuki Takamatsu, Hiroyuki Suzuki, Kenshi Min, Chang-Ki Lee, Jae Hoon Wang, Jianping Carson, Robin Crist, Wendy Qi, Ming Nagafuji, Koji